N-Nitrosopyrrolidine (NPYR) is a hepatocarcinogen in rats. It is metabolically activated by cytochrome P450 enzymes in the liver leading to the formation of 4-oxobutanediazohydroxide (4) and related intermediates that react with DNA to form adducts. Since DNA adducts are thought to be critical in carcinogenesis by NPYR, we analyzed hepatic DNA of NPYR-treated rats for several adducts: N 2 -(tetrahydrofuran-1-yl)dGuo (N 2 -THF-dGuo, 13), N 6 -THF-dAdo (14), N 4 -THF-dCyd (17), and dThd adducts 15 and 16. The rats were treated with NPYR in the drinking water, 600 ppm for 1 week, or 200 ppm for 4 or 13 weeks. Hepatic DNA was isolated, enzymatically hydrolyzed, and analyzed by capillary LC-ESI-MS-SIM, which indicated the presence of adducts 13, 14, and 17. Since these adducts can be unstable at the deoxyribonucleoside level, further analyses were carried out using DNA treated with NaBH 3 CN, which converts adducts 13-17 to (21) were (μmol/mol dGuo): 3. 41-5.39, 0.02-0.04, 2.56-3.87, and 2.28-5.05, respectively. N 4 -(4-HOB)-dCyd (22) was not quantified due to interfering peaks. These results provide the first evidence for tetrahydrofuranyl-substituted DNA adducts in the livers of rats treated with NPYR. The finding of dAdo and dThd adducts is of particular interest since previous studies have shown that NPYR causes mutations at AT base pairs in DNA of rat liver.